The centers for research are named for Anthony Greco, MD, and John Hainsworth, MD, who founded Sarah Cannon in 1993 as Tennessee Oncology physician researchers.
Tennessee Oncology, based in Nashville, is expanding its research footprint by launching the Greco-Hainsworth Tennessee Oncology Centers for Research, which will reach 35 clinical sites across Tennessee and Northwest Georgia, the practice announced today.
Ian Flinn, MD, PhD, a leading hematologist-oncologist who was previously director of Blood Cancer at Sarah Cannon Research Institute, will be chief scientific officer of the Greco-Hainsworth centers. Flinn, the author of more than 700 scientific papers, was formerly an associate professor of oncology at Johns Hopkins University, where he also received his PhD in Clinical Investigations and conducted his clinical fellowship in Oncology and Hematology.
In addition, Flinn will serve as chief scientific officer for OneOncology, the platform for independent oncologists of which Tennessee Oncology is a founding member.
The centers for research are named for Anthony Greco, MD, and John Hainsworth, MD, who founded Sarah Cannon in 1993 as Tennessee Oncology physician researchers.
Also joining the Greco-Hainsworth Tennessee Oncology Centers for Research is Heather Askew, who will serve as executive director of Research Operations. Askew served most recently as the senior director of Clinical Operations at NiKang Therapeutics and has more than 2 decades of experience in clinical research operations. She has worked in both community-based and academic research institutions.
“By launching the Greco-Hainsworth Tennessee Oncology Centers for Research, we’re building on our core research mission to begin a new chapter of clinical trial excellence at Tennessee Oncology,” said Natalie Dickson, MD, president and chief strategy officer, Tennessee Oncology. “With more than half of the state’s cancer population receiving care at Tennessee Oncology, our research platform provides an incredible opportunity to dramatically improve access to clinical trials for patients across Tennessee in both urban and rural communities.”
In their statement, Tennessee Oncology leaders say the Greco-Hainsworth Tennessee Oncology Centers for Research brings researchers “a platform to expand on their world-class research initiatives and reputation by offering a broad menu of clinical trials in all phases of drug development and CAR-T therapies, as well as studies examining access to clinical research, care delivery innovation, and the impact of social determinants of health.”
The practice’s footprint will allow investigators to examine the impact of clinical trials in both urban and rural regions.
“Our clinical research centers will provide an open architecture platform to expand research opportunities,” Flinn said. “We are looking forward to partnering with like-minded research institutions to advance innovation in oncology.”
The launch of the research centers is separate from Tennessee Oncology’s recent announcement of the McKay Institute for Oncology Transformation, which focuses on bringing changes to care delivery.
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Health Equity and Access Weekly Roundup: April 27, 2024
April 27th 2024Racial disparities in end-of-life care, the role of wellness and faith in minority health, award-winning research on health disparities, societal factors impacting cardiometabolic health, and rising mental health challenges among US youth are all covered this week in the Center on Health Equity and Access.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Patient Navigation in Oncology at Heart of Priority Health White House Visit
April 24th 2024On March 27, Priority Health's president and CEO, Praveen Thadani participated in a discussion on how to expand and optimize patient navigation services in oncology care, as part of the Cancer Moonshot initiative.
Read More